| Wave Life Sciences, Inc. | WVE | RA CAPITAL MANAGEMENT, L.P.DirDERIVJOINT | Oct 5 | A | 64,000 | $0.00 | —? |
| Wave Life Sciences, Inc. | WVE | RA CAPITAL MANAGEMENT, L.P.DirJOINT | Oct 5 | A | 10,700 | $0.00 | — |
| Vor Biopharma Inc. | VOR | RA CAPITAL MANAGEMENT, L.P.10%DERIVJOINT | Oct 2 | M | 500 | $0.00 | —? |
| Vor Biopharma Inc. | VOR | RA CAPITAL MANAGEMENT, L.P.10%JOINT | Oct 2 | M | 500 | $12.80 | $6K |
| Climb Bio, Inc. | CLYM | RA CAPITAL MANAGEMENT, L.P.DirDERIVJOINT | Sep 28 | M | 40,000 | $0.00 | —? |
| Climb Bio, Inc. | CLYM | RA CAPITAL MANAGEMENT, L.P.DirDERIVJOINT | Sep 28 | M | 10,000 | $0.00 | —? |
| Climb Bio, Inc. | CLYM | RA CAPITAL MANAGEMENT, L.P.DirDERIVJOINT | Sep 28 | M | 10,000 | $0.00 | —? |
| Climb Bio, Inc. | CLYM | RA CAPITAL MANAGEMENT, L.P.DirDERIVJOINT | Sep 28 | M | 10,000 | $0.00 | —? |
| Climb Bio, Inc. | CLYM | RA CAPITAL MANAGEMENT, L.P.DirJOINT | Sep 28 | M | 40,000 | $1.29 | $52K |
| Climb Bio, Inc. | CLYM | RA CAPITAL MANAGEMENT, L.P.DirJOINT | Sep 28 | M | 10,000 | $7.89 | $79K |
| Climb Bio, Inc. | CLYM | RA CAPITAL MANAGEMENT, L.P.DirJOINT | Sep 28 | M | 10,000 | $3.00 | $30K |
| Climb Bio, Inc. | CLYM | RA CAPITAL MANAGEMENT, L.P.DirJOINT | Sep 28 | M | 10,000 | $3.46 | $35K |
| Sionna Therapeutics, Inc. | SION | RA CAPITAL MANAGEMENT, L.P.DirJOINT | Sep 17 | S | 33,800 | $7.46 | $252K |
| Sionna Therapeutics, Inc. | SION | RA CAPITAL MANAGEMENT, L.P.DirJOINT | Sep 17 | S | 3,415,011 | $6.32 | $21.6M |
| Tyra Biosciences, Inc. | TYRA | RA CAPITAL MANAGEMENT, L.P.DirDERIVJOINT | Sep 15 | P | 9,078,529 | $22.03 | $200.0M? |
| Artiva Biotherapeutics, Inc. | ARTV | RA CAPITAL MANAGEMENT, L.P.DirDERIVJOINT | Sep 10 | A | 16,250 | $0.00 | —? |
| Artiva Biotherapeutics, Inc. | ARTV | RA CAPITAL MANAGEMENT, L.P.DirDERIVJOINT | Sep 8 | A | 13,750 | $0.00 | —? |
| Vor Biopharma Inc. | VOR | RA CAPITAL MANAGEMENT, L.P.10%DERIVJOINT | Aug 24 | M | 1,500 | $0.00 | —? |
| Vor Biopharma Inc. | VOR | RA CAPITAL MANAGEMENT, L.P.10%JOINT | Aug 24 | M | 1,500 | $3.74 | $6K |
| Septerna, Inc. | SEPN | RA CAPITAL MANAGEMENT, L.P.DirJOINT | Aug 12 | S | 746,500 | $42.50 | $31.7M |
| Septerna, Inc. | SEPN | RA CAPITAL MANAGEMENT, L.P.DirJOINT | Aug 12 | S | 746,500 | $42.50 | $31.7M |
| Inhibikase Therapeutics, Inc. | IKT | RA CAPITAL MANAGEMENT, L.P.10%DERIVJOINT | Jul 29 | J | 18,030,000 | — | — |
| Inhibikase Therapeutics, Inc. | IKT | RA CAPITAL MANAGEMENT, L.P.10%JOINT | Jul 29 | J | 18,030,000 | — | — |
| Artiva Biotherapeutics, Inc. | ARTV | RA CAPITAL MANAGEMENT, L.P.DirJOINT | Jul 31 | P | 24,944 | $9.93 | $248K |
| Artiva Biotherapeutics, Inc. | ARTV | RA CAPITAL MANAGEMENT, L.P.DirJOINT | Jul 29 | P | 20,824 | $9.99 | $208K |
| Artiva Biotherapeutics, Inc. | ARTV | RA CAPITAL MANAGEMENT, L.P.DirJOINT | Jul 24 | P | 41,319 | $9.99 | $413K |
| Artiva Biotherapeutics, Inc. | ARTV | RA CAPITAL MANAGEMENT, L.P.DirJOINT | Jul 23 | P | 59,880 | $9.96 | $596K |
| Artiva Biotherapeutics, Inc. | ARTV | RA CAPITAL MANAGEMENT, L.P.DirJOINT | Jul 22 | P | 84,124 | $9.93 | $835K |
| Artiva Biotherapeutics, Inc. | ARTV | RA CAPITAL MANAGEMENT, L.P.DirJOINT | Jul 21 | P | 120,582 | $9.55 | $1.2M |
| Parabilis Medicines, Inc. | PBLS | RA CAPITAL MANAGEMENT, L.P.DirJOINT | Jul 22 | P | 47,250 | $29.77 | $1.4M |
| Parabilis Medicines, Inc. | PBLS | RA CAPITAL MANAGEMENT, L.P.DirJOINT | Jul 21 | P | 37,723 | $30.00 | $1.1M |
| Parabilis Medicines, Inc. | PBLS | RA CAPITAL MANAGEMENT, L.P.DirJOINT | Jul 21 | P | 6,504 | $29.17 | $190K |
| Parabilis Medicines, Inc. | PBLS | RA CAPITAL MANAGEMENT, L.P.DirJOINT | Jul 21 | P | 21,696 | $27.96 | $607K |
| Parabilis Medicines, Inc. | PBLS | RA CAPITAL MANAGEMENT, L.P.DirJOINT | Jul 20 | P | 32,987 | $27.72 | $914K |
| Parabilis Medicines, Inc. | PBLS | RA CAPITAL MANAGEMENT, L.P.DirJOINT | Jul 20 | P | 98,433 | $27.13 | $2.7M |
| Freenome, Inc. | FRNM | RA CAPITAL MANAGEMENT, L.P.DirJOINT | Jul 20 | A | 336,965 | $10.00 | $3.4M |
| Freenome, Inc. | FRNM | RA CAPITAL MANAGEMENT, L.P.DirJOINT | Jul 20 | A | 4,918,411 | $10.00 | $49.2M |
| Freenome, Inc. | FRNM | RA CAPITAL MANAGEMENT, L.P.DirJOINT | Jul 20 | A | 367,427 | — | — |
| Freenome, Inc. | FRNM | RA CAPITAL MANAGEMENT, L.P.DirJOINT | Jul 20 | A | 908,103 | — | — |
| Freenome, Inc. | FRNM | RA CAPITAL MANAGEMENT, L.P.DirJOINT | Jul 20 | A | 553,703 | — | — |
| Freenome, Inc. | FRNM | RA CAPITAL MANAGEMENT, L.P.DirJOINT | Jul 20 | A | 970,950 | — | — |
| Freenome, Inc. | FRNM | RA CAPITAL MANAGEMENT, L.P.DirJOINT | Jul 20 | A | 6,561,711 | — | — |
| Vor Biopharma Inc. | VOR | RA CAPITAL MANAGEMENT, L.P.10%DERIVJOINT | Jul 16 | X | 2,100,000 | $5.00 | $10.5M? |
| Vor Biopharma Inc. | VOR | RA CAPITAL MANAGEMENT, L.P.10%JOINT | Jul 16 | S | 213 | $19.75 | $4K |
| Vor Biopharma Inc. | VOR | RA CAPITAL MANAGEMENT, L.P.10%JOINT | Jul 16 | X | 2,100,000 | $0.00 | $4K |
| Artiva Biotherapeutics, Inc. | ARTV | RA CAPITAL MANAGEMENT, L.P.DirJOINT | Jul 17 | P | 7,882 | $8.95 | $71K |
| Artiva Biotherapeutics, Inc. | ARTV | RA CAPITAL MANAGEMENT, L.P.DirJOINT | Jul 16 | P | 152,472 | $8.93 | $1.4M |
| Artiva Biotherapeutics, Inc. | ARTV | RA CAPITAL MANAGEMENT, L.P.DirJOINT | Jul 13 | P | 6,552 | $8.94 | $59K |
| Artiva Biotherapeutics, Inc. | ARTV | RA CAPITAL MANAGEMENT, L.P.DirJOINT | Jul 10 | P | 15,102 | $8.97 | $135K |
| Climb Bio, Inc. | CLYM | RA CAPITAL MANAGEMENT, L.P.DirDERIVJOINT | Jun 29 | A | 70,284 | $0.00 | —? |
| Septerna, Inc. | SEPN | RA CAPITAL MANAGEMENT, L.P.DirDERIVJOINT | Jun 26 | A | 15,000 | $0.00 | —? |
| Artiva Biotherapeutics, Inc. | ARTV | RA CAPITAL MANAGEMENT, L.P.DirJOINT | Jun 26 | P | 1,876 | $8.98 | $17K |
| Artiva Biotherapeutics, Inc. | ARTV | RA CAPITAL MANAGEMENT, L.P.DirJOINT | Jun 25 | P | 31,000 | $8.88 | $275K |
| ARS Pharmaceuticals, Inc. | SPRY | RA CAPITAL MANAGEMENT, L.P.DirDERIVJOINT | Jun 24 | A | 30,000 | $0.00 | —? |
| Werewolf Therapeutics, Inc. | HOWL | RA CAPITAL MANAGEMENT, L.P.10%JOINT | Jun 17 | S | 27,695 | $0.35 | $10K |
| Werewolf Therapeutics, Inc. | HOWL | RA CAPITAL MANAGEMENT, L.P.10%JOINT | Jun 17 | S | 389,216 | $0.35 | $136K |
| PepGen Inc. | PEPG | RA CAPITAL MANAGEMENT, L.P.DirDERIVJOINT | Jun 18 | A | 34,000 | $0.00 | —? |
| Acrivon Therapeutics, Inc. | ACRV | RA CAPITAL MANAGEMENT, L.P.DirDERIVJOINT | Jun 17 | A | 20,275 | $0.00 | —? |
| Sionna Therapeutics, Inc. | SION | RA CAPITAL MANAGEMENT, L.P.DirDERIVJOINT | Jun 17 | A | 17,340 | $0.00 | —? |
| Hemab Therapeutics Holdings, Inc. | COAG | RA CAPITAL MANAGEMENT, L.P.10%JOINT | Jun 16 | P | 61,523 | $24.98 | $1.5M |
| Hemab Therapeutics Holdings, Inc. | COAG | RA CAPITAL MANAGEMENT, L.P.10%JOINT | Jun 15 | P | 6,146 | $24.89 | $153K |
| Werewolf Therapeutics, Inc. | HOWL | RA CAPITAL MANAGEMENT, L.P.10%JOINT | Jun 16 | S | 9,939 | $0.37 | $4K |
| Werewolf Therapeutics, Inc. | HOWL | RA CAPITAL MANAGEMENT, L.P.10%JOINT | Jun 16 | S | 139,686 | $0.37 | $52K |
| Werewolf Therapeutics, Inc. | HOWL | RA CAPITAL MANAGEMENT, L.P.10%JOINT | Jun 15 | S | 8,554 | $0.39 | $3K |
| Werewolf Therapeutics, Inc. | HOWL | RA CAPITAL MANAGEMENT, L.P.10%JOINT | Jun 15 | S | 120,216 | $0.39 | $47K |
| Werewolf Therapeutics, Inc. | HOWL | RA CAPITAL MANAGEMENT, L.P.10%JOINT | Jun 12 | S | 11,322 | $0.40 | $5K |
| Werewolf Therapeutics, Inc. | HOWL | RA CAPITAL MANAGEMENT, L.P.10%JOINT | Jun 12 | S | 159,119 | $0.40 | $64K |
| Artiva Biotherapeutics, Inc. | ARTV | RA CAPITAL MANAGEMENT, L.P.DirJOINT | Jun 16 | P | 124,893 | $8.89 | $1.1M |
| Artiva Biotherapeutics, Inc. | ARTV | RA CAPITAL MANAGEMENT, L.P.DirJOINT | Jun 15 | P | 15,414 | $8.99 | $139K |
| Artiva Biotherapeutics, Inc. | ARTV | RA CAPITAL MANAGEMENT, L.P.DirJOINT | Jun 12 | P | 391,019 | $8.57 | $3.4M |
| LENZ Therapeutics, Inc. | LENZ | RA CAPITAL MANAGEMENT, L.P.DirDERIVJOINT | Jun 15 | A | 22,100 | $0.00 | —? |
| Parabilis Medicines, Inc. | PBLS | RA CAPITAL MANAGEMENT, L.P.DirDERIVJOINT | Jun 11 | C | 1,666,829 | — | — |
| Parabilis Medicines, Inc. | PBLS | RA CAPITAL MANAGEMENT, L.P.DirDERIVJOINT | Jun 11 | C | 9,445,363 | — | — |
| Parabilis Medicines, Inc. | PBLS | RA CAPITAL MANAGEMENT, L.P.DirDERIVJOINT | Jun 11 | C | 160,562 | — | — |
| Parabilis Medicines, Inc. | PBLS | RA CAPITAL MANAGEMENT, L.P.DirDERIVJOINT | Jun 11 | C | 642,250 | — | — |
| Parabilis Medicines, Inc. | PBLS | RA CAPITAL MANAGEMENT, L.P.DirJOINT | Jun 11 | P | 1,460,397 | $20.00 | $29.2M |
| Parabilis Medicines, Inc. | PBLS | RA CAPITAL MANAGEMENT, L.P.DirJOINT | Jun 11 | P | 19,728,353 | $20.00 | $394.6M |
| Parabilis Medicines, Inc. | PBLS | RA CAPITAL MANAGEMENT, L.P.DirJOINT | Jun 11 | C | 1,187,881 | — | — |
| Parabilis Medicines, Inc. | PBLS | RA CAPITAL MANAGEMENT, L.P.DirJOINT | Jun 11 | C | 6,556,740 | — | — |
| Vor Biopharma Inc. | VOR | RA CAPITAL MANAGEMENT, L.P.DirDERIVJOINT | Jun 11 | A | 57,162 | $0.00 | —? |
| Janux Therapeutics, Inc. | JANX | RA CAPITAL MANAGEMENT, L.P.DirDERIVJOINT | Jun 11 | A | 15,500 | $0.00 | —? |
| Janux Therapeutics, Inc. | JANX | RA CAPITAL MANAGEMENT, L.P.DirJOINT | Jun 11 | A | 5,500 | $0.00 | — |
| Werewolf Therapeutics, Inc. | HOWL | RA CAPITAL MANAGEMENT, L.P.10%JOINT | Jun 11 | S | 17,437 | $0.38 | $7K |
| Werewolf Therapeutics, Inc. | HOWL | RA CAPITAL MANAGEMENT, L.P.10%JOINT | Jun 11 | S | 245,066 | $0.38 | $93K |
| Werewolf Therapeutics, Inc. | HOWL | RA CAPITAL MANAGEMENT, L.P.10%JOINT | Jun 10 | S | 3,051 | $0.37 | $1K |
| Werewolf Therapeutics, Inc. | HOWL | RA CAPITAL MANAGEMENT, L.P.10%JOINT | Jun 10 | S | 42,872 | $0.37 | $16K |
| Werewolf Therapeutics, Inc. | HOWL | RA CAPITAL MANAGEMENT, L.P.10%JOINT | Jun 9 | S | 24,565 | $0.37 | $9K |
| Werewolf Therapeutics, Inc. | HOWL | RA CAPITAL MANAGEMENT, L.P.10%JOINT | Jun 9 | S | 345,235 | $0.37 | $128K |
| Parabilis Medicines, Inc. | PBLS | RA CAPITAL MANAGEMENT, L.P.DirDERIVJOINT | Jun 9 | A | 20,215 | $0.00 | —? |
| Nkarta, Inc. | NKTX | RA CAPITAL MANAGEMENT, L.P.DirDERIVJOINT | Jun 10 | A | 37,000 | $0.00 | —? |
| Artiva Biotherapeutics, Inc. | ARTV | RA CAPITAL MANAGEMENT, L.P.DirJOINT | Jun 11 | P | 548,580 | $7.91 | $4.3M |
| Artiva Biotherapeutics, Inc. | ARTV | RA CAPITAL MANAGEMENT, L.P.DirJOINT | Jun 10 | P | 103 | $7.00 | $721 |
| Artiva Biotherapeutics, Inc. | ARTV | RA CAPITAL MANAGEMENT, L.P.DirJOINT | Jun 9 | P | 479,039 | $6.91 | $3.3M |
| Bicara Therapeutics Inc. | BCAX | RA CAPITAL MANAGEMENT, L.P.DirDERIVJOINT | Jun 9 | A | 19,475 | $0.00 | —? |
| Climb Bio, Inc. | CLYM | RA CAPITAL MANAGEMENT, L.P.DirDERIVJOINT | Jun 5 | A | 40,000 | $0.00 | —? |
| Acumen Pharmaceuticals, Inc. | ABOS | RA CAPITAL MANAGEMENT, L.P.DirDERIVJOINT | Jun 3 | A | 53,250 | $0.00 | —? |
| Acumen Pharmaceuticals, Inc. | ABOS | RA CAPITAL MANAGEMENT, L.P.DirJOINT | Jun 3 | A | 35,500 | $0.00 | — |
| Tyra Biosciences, Inc. | TYRA | RA CAPITAL MANAGEMENT, L.P.DirDERIVJOINT | May 28 | A | 13,160 | $0.00 | —? |
| Hemab Therapeutics Holdings, Inc. | COAG | RA CAPITAL MANAGEMENT, L.P.10%JOINT | May 20 | P | 996 | $24.94 | $25K |
| Hemab Therapeutics Holdings, Inc. | COAG | RA CAPITAL MANAGEMENT, L.P.10%JOINT | May 19 | P | 3,802 | $24.97 | $95K |
| Acrivon Therapeutics, Inc. | ACRV | RA CAPITAL MANAGEMENT, L.P.DirJOINT | May 18 | A | 9,366 | $0.00 | — |
| Hemab Therapeutics Holdings, Inc. | COAG | RA CAPITAL MANAGEMENT, L.P.10%JOINT | May 12 | P | 6,387 | $24.90 | $159K |
| Artiva Biotherapeutics, Inc. | ARTV | RA CAPITAL MANAGEMENT, L.P.DirDERIVJOINT | May 11 | P | 2,170,138 | $11.52 | $25.0M? |
| Artiva Biotherapeutics, Inc. | ARTV | RA CAPITAL MANAGEMENT, L.P.DirJOINT | May 11 | P | 6,510,416 | $11.52 | $75.0M |
| Werewolf Therapeutics, Inc. | HOWL | RA CAPITAL MANAGEMENT, L.P.10%JOINT | May 12 | S | 6,719 | $0.64 | $4K |
| Werewolf Therapeutics, Inc. | HOWL | RA CAPITAL MANAGEMENT, L.P.10%JOINT | May 12 | S | 94,432 | $0.64 | $60K |
| Werewolf Therapeutics, Inc. | HOWL | RA CAPITAL MANAGEMENT, L.P.10%JOINT | May 11 | S | 5,812 | $0.67 | $4K |
| Werewolf Therapeutics, Inc. | HOWL | RA CAPITAL MANAGEMENT, L.P.10%JOINT | May 11 | S | 81,678 | $0.67 | $55K |
| Werewolf Therapeutics, Inc. | HOWL | RA CAPITAL MANAGEMENT, L.P.10%JOINT | May 8 | S | 25,012 | $0.71 | $18K |
| Werewolf Therapeutics, Inc. | HOWL | RA CAPITAL MANAGEMENT, L.P.10%JOINT | May 8 | S | 351,514 | $0.71 | $250K |
| Hemab Therapeutics Holdings, Inc. | COAG | RA CAPITAL MANAGEMENT, L.P.10%JOINT | May 11 | P | 25,720 | $25.00 | $643K |
| Hemab Therapeutics Holdings, Inc. | COAG | RA CAPITAL MANAGEMENT, L.P.10%JOINT | May 11 | P | 14,149 | $24.47 | $346K |
| Hemab Therapeutics Holdings, Inc. | COAG | RA CAPITAL MANAGEMENT, L.P.10%JOINT | May 8 | P | 1,483 | $24.98 | $37K |
| Hemab Therapeutics Holdings, Inc. | COAG | RA CAPITAL MANAGEMENT, L.P.10%JOINT | May 7 | P | 1,985 | $24.95 | $50K |
| Hemab Therapeutics Holdings, Inc. | COAG | RA CAPITAL MANAGEMENT, L.P.10%JOINT | May 7 | P | 7,921 | $24.34 | $193K |
| Hemab Therapeutics Holdings, Inc. | COAG | RA CAPITAL MANAGEMENT, L.P.DirDERIVJOINT | May 4 | C | 10,054 | — | — |
| Hemab Therapeutics Holdings, Inc. | COAG | RA CAPITAL MANAGEMENT, L.P.DirDERIVJOINT | May 4 | C | 56,972 | — | — |
| Hemab Therapeutics Holdings, Inc. | COAG | RA CAPITAL MANAGEMENT, L.P.DirDERIVJOINT | May 4 | C | 18,146 | — | — |
| Hemab Therapeutics Holdings, Inc. | COAG | RA CAPITAL MANAGEMENT, L.P.DirDERIVJOINT | May 4 | C | 42,341 | — | — |
| Hemab Therapeutics Holdings, Inc. | COAG | RA CAPITAL MANAGEMENT, L.P.DirDERIVJOINT | May 4 | C | 27,720 | — | — |
| Hemab Therapeutics Holdings, Inc. | COAG | RA CAPITAL MANAGEMENT, L.P.DirDERIVJOINT | May 4 | C | 64,680 | — | — |
| Hemab Therapeutics Holdings, Inc. | COAG | RA CAPITAL MANAGEMENT, L.P.DirJOINT | May 6 | P | 53,407 | $24.83 | $1.3M |
| Hemab Therapeutics Holdings, Inc. | COAG | RA CAPITAL MANAGEMENT, L.P.DirJOINT | May 6 | P | 14,611 | $23.77 | $347K |
| Hemab Therapeutics Holdings, Inc. | COAG | RA CAPITAL MANAGEMENT, L.P.DirJOINT | May 5 | P | 10,268 | $25.00 | $257K |
| Hemab Therapeutics Holdings, Inc. | COAG | RA CAPITAL MANAGEMENT, L.P.DirJOINT | May 5 | P | 87,143 | $24.59 | $2.1M |
| Hemab Therapeutics Holdings, Inc. | COAG | RA CAPITAL MANAGEMENT, L.P.DirJOINT | May 4 | P | 133,750 | $18.00 | $2.4M |
| Hemab Therapeutics Holdings, Inc. | COAG | RA CAPITAL MANAGEMENT, L.P.DirJOINT | May 4 | P | 2,541,250 | $18.00 | $45.7M |
| Hemab Therapeutics Holdings, Inc. | COAG | RA CAPITAL MANAGEMENT, L.P.DirJOINT | May 4 | C | 221,188 | — | — |
| Hemab Therapeutics Holdings, Inc. | COAG | RA CAPITAL MANAGEMENT, L.P.DirJOINT | May 4 | C | 1,009,052 | — | — |
| Hemab Therapeutics Holdings, Inc. | COAG | RA CAPITAL MANAGEMENT, L.P.DirJOINT | May 4 | C | 3,607,846 | — | — |
| Climb Bio, Inc. | CLYM | RA CAPITAL MANAGEMENT, L.P.DirDERIVJOINT | Apr 29 | A | 2,106,000 | $9.50 | $20.0M? |
| Adicet Bio, Inc. | ACET | RA CAPITAL MANAGEMENT, L.P.10%DERIVJOINT | Apr 27 | J | 250,000 | — | — |
| Adicet Bio, Inc. | ACET | RA CAPITAL MANAGEMENT, L.P.10%JOINT | Apr 27 | J | 250,000 | — | — |
| Prelude Therapeutics Inc | PRLD | RA CAPITAL MANAGEMENT, L.P.10%DERIVJOINT | Apr 27 | J | 1,407,000 | — | — |
| Prelude Therapeutics Inc | PRLD | RA CAPITAL MANAGEMENT, L.P.10%JOINT | Apr 27 | J | 1,407,000 | — | — |
| Vor Biopharma Inc. | VOR | RA CAPITAL MANAGEMENT, L.P.DirJOINT | Apr 22 | S | 165,150 | $15.77 | $2.6M |
| Acrivon Therapeutics, Inc. | ACRV | RA CAPITAL MANAGEMENT, L.P.DirJOINT | Apr 22 | A | 3,888,888 | $1.80 | $7.0M |
| Vor Biopharma Inc. | VOR | RA CAPITAL MANAGEMENT, L.P.DirJOINT | Apr 20 | S | 171,963 | $15.77 | $2.7M |
| Vor Biopharma Inc. | VOR | RA CAPITAL MANAGEMENT, L.P.DirJOINT | Apr 17 | S | 458,411 | $16.28 | $7.5M |
| Vor Biopharma Inc. | VOR | RA CAPITAL MANAGEMENT, L.P.DirJOINT | Apr 15 | S | 53,644 | $16.01 | $859K |
| Vor Biopharma Inc. | VOR | RA CAPITAL MANAGEMENT, L.P.DirJOINT | Apr 14 | S | 153,735 | $15.97 | $2.5M |
| Vor Biopharma Inc. | VOR | RA CAPITAL MANAGEMENT, L.P.DirJOINT | Apr 13 | S | 530,610 | $16.15 | $8.6M |
| Adicet Bio, Inc. | ACET | RA CAPITAL MANAGEMENT, L.P.10%JOINT | Feb 20 | P | 74,751 | $7.27 | $543K |
| Adicet Bio, Inc. | ACET | RA CAPITAL MANAGEMENT, L.P.10%JOINT | Feb 19 | P | 74,268 | $7.21 | $535K |
| Adicet Bio, Inc. | ACET | RA CAPITAL MANAGEMENT, L.P.10%JOINT | Feb 18 | P | 74,577 | $7.04 | $525K |
| Vor Biopharma Inc. | VOR | RA CAPITAL MANAGEMENT, L.P.DirJOINT | Apr 10 | S | 828 | $15.75 | $13K |
| Vor Biopharma Inc. | VOR | RA CAPITAL MANAGEMENT, L.P.DirJOINT | Apr 9 | S | 135,201 | $16.59 | $2.2M |
| Vor Biopharma Inc. | VOR | RA CAPITAL MANAGEMENT, L.P.DirJOINT | Apr 8 | S | 130,862 | $16.91 | $2.2M |
| Vor Biopharma Inc. | VOR | RA CAPITAL MANAGEMENT, L.P.DirJOINT | Apr 8 | S | 353,242 | $16.32 | $5.8M |
| Vor Biopharma Inc. | VOR | RA CAPITAL MANAGEMENT, L.P.DirJOINT | Apr 6 | S | 6,775 | $18.50 | $125K |
| Vor Biopharma Inc. | VOR | RA CAPITAL MANAGEMENT, L.P.DirJOINT | Apr 6 | S | 44,728 | $17.31 | $774K |
| Vor Biopharma Inc. | VOR | RA CAPITAL MANAGEMENT, L.P.DirJOINT | Apr 6 | S | 537,754 | $16.51 | $8.9M |
| Vor Biopharma Inc. | VOR | RA CAPITAL MANAGEMENT, L.P.DirJOINT | Apr 2 | S | 1,525 | $19.06 | $29K |
| Vor Biopharma Inc. | VOR | RA CAPITAL MANAGEMENT, L.P.DirJOINT | Apr 2 | S | 258,475 | $18.23 | $4.7M |
| Mineralys Therapeutics, Inc. | MLYS | RA CAPITAL MANAGEMENT, L.P.DirJOINT | Mar 30 | P | 58,300 | $24.16 | $1.4M |
| Mineralys Therapeutics, Inc. | MLYS | RA CAPITAL MANAGEMENT, L.P.DirJOINT | Mar 27 | P | 310,700 | $23.67 | $7.4M |
| Wave Life Sciences Ltd. | WVE | RA CAPITAL MANAGEMENT, L.P.DirJOINT | Mar 30 | P | 971,091 | $6.50 | $6.3M |
| Wave Life Sciences Ltd. | WVE | RA CAPITAL MANAGEMENT, L.P.DirJOINT | Mar 27 | P | 2,495,623 | $6.43 | $16.0M |
| Wave Life Sciences Ltd. | WVE | RA CAPITAL MANAGEMENT, L.P.DirJOINT | Mar 26 | P | 351,224 | $6.38 | $2.2M |
| Wave Life Sciences Ltd. | WVE | RA CAPITAL MANAGEMENT, L.P.DirJOINT | Mar 26 | P | 4,954,558 | $6.06 | $30.0M |
| Acumen Pharmaceuticals, Inc. | ABOS | RA CAPITAL MANAGEMENT, L.P.DirJOINT | Mar 16 | A | 6,060,606 | $3.30 | $20.0M |
| Bicara Therapeutics Inc. | BCAX | RA CAPITAL MANAGEMENT, L.P.DirDERIVJOINT | Feb 26 | P | 2,200,000 | $16.00 | $35.2M? |
| Bicara Therapeutics Inc. | BCAX | RA CAPITAL MANAGEMENT, L.P.DirJOINT | Feb 26 | P | 300,000 | $16.00 | $4.8M |
| Mineralys Therapeutics, Inc. | MLYS | RA CAPITAL MANAGEMENT, L.P.DirDERIVJOINT | Feb 19 | A | 8,300 | $0.00 | —? |
| Mineralys Therapeutics, Inc. | MLYS | RA CAPITAL MANAGEMENT, L.P.DirJOINT | Feb 19 | A | 6,200 | $0.00 | — |
| Evommune, Inc. | EVMN | RA CAPITAL MANAGEMENT, L.P.DirJOINT | Feb 17 | A | 35,868 | $27.88 | $1000K |
| SpyGlass Pharma, Inc. | SGP | RA CAPITAL MANAGEMENT, L.P.DirDERIVJOINT | Feb 9 | C | 272,056 | — | — |
| SpyGlass Pharma, Inc. | SGP | RA CAPITAL MANAGEMENT, L.P.DirDERIVJOINT | Feb 9 | C | 222,591 | — | — |
| SpyGlass Pharma, Inc. | SGP | RA CAPITAL MANAGEMENT, L.P.DirDERIVJOINT | Feb 9 | C | 767,294 | — | — |
| SpyGlass Pharma, Inc. | SGP | RA CAPITAL MANAGEMENT, L.P.DirDERIVJOINT | Feb 9 | C | 1,150,941 | — | — |
| SpyGlass Pharma, Inc. | SGP | RA CAPITAL MANAGEMENT, L.P.DirDERIVJOINT | Feb 9 | C | 767,294 | — | — |
| SpyGlass Pharma, Inc. | SGP | RA CAPITAL MANAGEMENT, L.P.DirDERIVJOINT | Feb 9 | C | 1,150,941 | — | — |
| SpyGlass Pharma, Inc. | SGP | RA CAPITAL MANAGEMENT, L.P.DirJOINT | Feb 9 | P | 248,034 | $16.00 | $4.0M |
| SpyGlass Pharma, Inc. | SGP | RA CAPITAL MANAGEMENT, L.P.DirJOINT | Feb 9 | P | 3,441,966 | $16.00 | $55.1M |
| SpyGlass Pharma, Inc. | SGP | RA CAPITAL MANAGEMENT, L.P.DirJOINT | Feb 9 | C | 1,806,644 | — | — |
| SpyGlass Pharma, Inc. | SGP | RA CAPITAL MANAGEMENT, L.P.DirJOINT | Feb 9 | C | 2,524,473 | — | — |
| SpyGlass Pharma, Inc. | SGP | RA CAPITAL MANAGEMENT, L.P.DirDERIVJOINT | Feb 5 | A | 27,400 | $0.00 | —? |
| Cidara Therapeutics, Inc. | CDTX | RA CAPITAL MANAGEMENT, L.P.DirDERIVJOINT | Jan 7 | D | 89,956 | $15,505.00 | $1.4B? |
| Cidara Therapeutics, Inc. | CDTX | RA CAPITAL MANAGEMENT, L.P.DirDERIVJOINT | Jan 7 | M | 1,286,786 | — | — |
| Cidara Therapeutics, Inc. | CDTX | RA CAPITAL MANAGEMENT, L.P.DirDERIVJOINT | Jan 7 | D | 5,079 | — | — |
| Cidara Therapeutics, Inc. | CDTX | RA CAPITAL MANAGEMENT, L.P.DirDERIVJOINT | Jan 7 | D | 22,200 | — | — |
| Cidara Therapeutics, Inc. | CDTX | RA CAPITAL MANAGEMENT, L.P.DirJOINT | Jan 7 | D | 4,652,309 | $221.50 | $1.0B? |
| Cidara Therapeutics, Inc. | CDTX | RA CAPITAL MANAGEMENT, L.P.DirJOINT | Jan 7 | M | 1,286,786 | $0.00 | $129 |
| Climb Bio, Inc. | CLYM | RA CAPITAL MANAGEMENT, L.P.DirJOINT | Jan 5 | P | 7,111 | $3.50 | $25K |
| Climb Bio, Inc. | CLYM | RA CAPITAL MANAGEMENT, L.P.DirDERIVJOINT | Dec 11 | A | 20,440,000 | — | — |
| Climb Bio, Inc. | CLYM | RA CAPITAL MANAGEMENT, L.P.DirJOINT | Dec 12 | P | 101,462 | $2.86 | $290K |
| Climb Bio, Inc. | CLYM | RA CAPITAL MANAGEMENT, L.P.DirJOINT | Dec 11 | P | 213,099 | $2.18 | $465K |
| Climb Bio, Inc. | CLYM | RA CAPITAL MANAGEMENT, L.P.DirJOINT | Dec 11 | D | 20,440,000 | $0.00 | — |
| 89bio, Inc. | ETNB | RA CAPITAL MANAGEMENT, L.P.DirDERIVJOINT | Oct 30 | D | 56,400 | $0.00 | —? |
| 89bio, Inc. | ETNB | RA CAPITAL MANAGEMENT, L.P.DirDERIVJOINT | Oct 30 | D | 45,150 | $0.00 | —? |
| 89bio, Inc. | ETNB | RA CAPITAL MANAGEMENT, L.P.DirDERIVJOINT | Oct 30 | D | 27,400 | $0.00 | —? |
| 89bio, Inc. | ETNB | RA CAPITAL MANAGEMENT, L.P.DirDERIVJOINT | Oct 30 | D | 25,000 | $0.00 | —? |
| 89bio, Inc. | ETNB | RA CAPITAL MANAGEMENT, L.P.DirDERIVJOINT | Oct 30 | D | 12,500 | $0.00 | —? |
| 89bio, Inc. | ETNB | RA CAPITAL MANAGEMENT, L.P.DirDERIVJOINT | Oct 30 | D | 7,000 | $0.00 | —? |
| 89bio, Inc. | ETNB | RA CAPITAL MANAGEMENT, L.P.DirDERIVJOINT | Oct 30 | D | 7,000 | $0.00 | —? |
| 89bio, Inc. | ETNB | RA CAPITAL MANAGEMENT, L.P.DirDERIVJOINT | Oct 30 | D | 4,331,081 | $0.00 | —? |
| 89bio, Inc. | ETNB | RA CAPITAL MANAGEMENT, L.P.DirJOINT | Oct 30 | D | 335,364 | — | — |
| 89bio, Inc. | ETNB | RA CAPITAL MANAGEMENT, L.P.DirJOINT | Oct 30 | D | 19,554,319 | — | — |